Literature DB >> 11834253

Venodilator action of an organotransition-metal nitrosyl complex.

Kenneth S Poon1, Catherine C Y Pang.   

Abstract

Nitrovasodilators, such as nitroglycerin, cause endothelium-independent dilatation of arterial and capacitance vessels via the release of nitric oxide (NO). This study examined the venodilator effect of CpCr(NO)(2)Cl (organotransition-metal nitrosyl complex) relative to that of nitroglycerin in conscious, unrestrained rats. Organotransition-metal nitrosyl complexes have releasable NO directly attached to metal centres. The dose-response effects of CpCr(NO)(2)Cl and nitroglycerin on the mean arterial pressure and the mean circulatory filling pressure (index of the body venous tone) were obtained in rats continuously infused with either normal saline or noradrenaline. The results show that both CpCr(NO)(2)Cl and nitroglycerin reduced the mean arterial pressure in rats with normal or elevated vasomotor tone. However, maximum depressor response of CpCr(NO)(2)Cl was greater than that of nitroglycerin. In vehicle-treated rats, both compounds increased the mean circulatory filling pressure. In rats with elevated vasomotor tone through the infusion of noradrenaline, both agents reduced the mean circulatory filling pressure. These results show that CpCr(NO)(2)Cl is an efficacious depressor and venodilator agent.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834253     DOI: 10.1016/s0014-2999(01)01612-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Effect of intermedin/adrenomedullin-2 on venous tone in conscious rats.

Authors:  Aly M Abdelrahman; Catherine C Y Pang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-31       Impact factor: 3.000

2.  The individual survival benefits of tumor necrosis factor soluble receptor and fluid administration are not additive in a rat sepsis model.

Authors:  Ping Qiu; Yan Li; Yi Ding; Jia Weng; Steven M Banks; Steven Kern; Yvonne Fitz; Anthony F Suffredini; Peter Q Eichacker; Xizhong Cui
Journal:  Intensive Care Med       Date:  2011-08-30       Impact factor: 17.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.